Illumina, Facing Dip in Array Demand, Posts 12-Percent Rise in Q4 Sales

Product revenue for the quarter rose 10 percent on "significant growth" in its sequencing products. Instruments sales rose 19 percent largely on the back of "strong growth in sequencing instrumentation, which was partially offset by lower sales of array instruments during the quarter."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.